We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Cardiology

You are here

QP ExCELs: Sentus QP – Extended CRT Evaluation with Quadripolar Left Ventricular

IRB Protocol #: 1704018134

ClinicalTrials.gov Identifier: NCT02290028

Overview: The purpose of this study is to confirm the long-term safety of the BIOTRONIK Sentus QP lead used with the BIOTRONIK CRT-D device. These leads are legally marketed in the United States and not investigational products. The study involves collection and review of data at regular follow-up visits with your doctor.

This trial is funded by BIOTRONIK.

To be eligible, patients must:

  • Be a candidate for CRT-D
  • Be able and willing to complete all routine study visits at our site through five years of follow up
  • Accept Home Monitoring® concept

Patients cannot participate if they have:

  • A left ventricular lead already implanted or had prior attempt to place a left ventricular lead
  • A cardiac surgical procedure, such as coronary artery bypass graft or valve surgery that is planned to occur within 6 months after implant or ablation that is planned to occur within 90 days after implant
  • Another life-threatening, underlying illness separate from their cardiac disorder

 

Contact:

Dr. George Thomas
Principle Investigator
Email: Get2007@med.cornell.edu
Phone: (212) 746-2158 

Grace Lee
Research Coordinator
Email: Grl2008@med.cornell.edu
Phone: (646) 962-8493

Make an Appointment

(646) 962-5558

Weill Cornell Medicine
Division of Cardiology

520 East 70th Street
Starr 443
New York, NY 10021

1305 York Avenue, 8th Floor
New York, NY 10021